Cardiomagnyl tablets film-coated

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

acetylsalicylic acid, magnesium hydroxide

Available from:

Takeda GmbH

ATC code:

B01AC30

INN (International Name):

acetylsalicylic acid, magnesium hydroxide

Dosage:

75mg+ 15.2mg

Pharmaceutical form:

tablets film-coated

Units in package:

(30) and (100) in glass container

Prescription type:

OTC

Authorization status:

Registered

Authorization date:

2021-10-08

Summary of Product characteristics

1
SUMMARY OF PRODUCT CHARACTERISTICS
FOR
СARDIOMAGNYL, FILM COATED TABLETS 75 MG
1.
NAME OF THE MEDICINAL
PRODUCT
Cardiomagnyl
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 75 mg acetylsalicylic acid and 15,2mg
magnesium hydroxide
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablets
White film-coated tablets shaped as a stylized “heart”
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Primary prophylaxis of cardiovascular disorders, such as thrombosis
and acute heart insufficiency
in high-risk patient groups (e.g. having diabetes mellitus,
hyperlipidemia, arterial hypertension,
obesity, smoking, and elderly age).
Prevention of recurrent myocardial infarction and vascular thrombosis.
Prevention of thromboembolism after surgical intervention on blood
vessels (aortocoronary shunting,
transdermal transluminal coronary angioplasty).
Unstable angina pectoris.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The tablets are to be swallowed whole with a drink of water. If
desired, a tablet can be broken into
two, chewed or triturated.
PRIMARY
PROPHYLAXIS
OF
CARDIOVASCULAR
DISORDERS,
SUCH
AS
THROMBOSIS
AND
ACUTE
HEART
INSUFFICIENCY IN HIGH-RISK PATIENT GROUPS (E.G. HAVING DIABETES
MELLITUS, HYPERLIPIDEMIA, ARTERIAL
HYPERTENSION, OBESITY, SMOKING, AND ELDERLY AGE)
One tablet of Cardiomagnyl containing 150 mg of ASA on day 1,
thereafter one tablet of
Cardiomagnyl containing 75 mg once daily.
2
PREVENTION OF RECURRENT MYOCARDIAL INFARCTION AND VASCULAR THROMBOSIS
One tablet of cardiomagnyl containing 75-150 mg of ASA once daily.
PREVENTION OF THROMBOEMBOLISM AFTER SURGICAL INTERVENTION ON BLOOD
VESSELS (AORTOCORONARY
SHUNTING, TRANSDERMAL TRANSLUMINAL CORONARY ANGIOPLASTY)
One tablet of Cardiomagnyl containing 75-150 mg of ASA once daily.
UNSTABLE ANGINA PECTORIS
One tablet of Cardiomagnyl containing 75-150 mg of ASA once daily.
4.3
CONTRAINDICATIONS
Hypersensitivity to ASA, excipients of Cardiomagnyl, and other
non-steroidal anti-inflammatory
drugs; cerebral hemorrha